基于高通量测序的胚胎追踪系统用于胚胎植入前遗传学检测
本研究开发了胚胎追踪系统(ETS),用于改善基于高通量测序的胚胎植入前遗传学检测(PGT)的安全性、效率和可扩展性。研究对322份全基因组扩增的胚胎DNA样本和563份亲本外周血DNA样本进行ETS-PGT流程,并与无ETS流程比较。结果显示ETS-PGT可降低样本混淆风险,且对胚胎基因组图谱无影响,同时提高效率和通量。
要点
- ETS-PGT将整个PGT流程中需双人核对步骤从6步减少至1步。
- ETS对植入前胚胎的基因组图谱无影响。
- ETS-PGT提高基于测序的PGT方法的效率和通量。
核心结论
- 应用ETS-PGT可降低样本混淆风险,同时可轻松大幅提高可扩展性和效率。
研究设计与样本
- 研究开发了ETS以简化当前基于测序的PGT流程。
- 使用ETS(n=693)和无ETS(n=192)对批量DNA样本(n=563)和全基因组扩增的少量细胞DNA样本(n=322)进行下游PGT操作。
- 比较含ETS或不含ETS的全基因组扩增样本和批量DNA样本的全基因组单倍型图谱。
- 纳入322份源自IVF胚胎的全基因组扩增DNA样本以及563份从意向父母外周血分离的批量DNA。
主要发现
- 当前PGT方案对质量敏感且易发生样本混淆,临床设置中需手动执行六个控制步骤并由第二人核对。
- ETS方法中整个PGT流程仅需一步双人核对原则。
- ETS不仅避免了易出错的手动检查,而且对植入前胚胎的基因组图谱无影响。
- 该方法提高了当前PGT方法的效率和通量。
临床怎么用
- 原文未据此给出推荐。
局限性
- 尽管ETS通过避免方案中六个步骤的潜在错误简化了基于测序的PGT,但如果初始分配执行不正确,可能导致交叉污染。
- 交叉污染可在下游ETS分析后通过计算机模拟检测。
- 虽然研究展示了一种评估ETS片段纯度的方法,但建议在PGT前使用非人类DNA对ETS扩增子进行质量控制测定,以便在ETS-PGT前确定每个ETS分子的纯度。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Can the embryo tracking system (ETS) increase safety, efficacy and scalability of massively parallel sequencing-based preimplantation genetic testing (PGT)? SUMMARY ANSWER: Applying ETS-PGT, the chance of sample switching is decreased, while scalability and efficacy could easily be increased substantially. WHAT IS KNOWN ALREADY: Although state-of-the-art sequencing-based PGT methods made a paradigm shift in PGT, they still require labor intensive library preparation steps that makes PGT cost prohibitive and poses risks of human errors. To increase the quality assurance, efficiency, robustness and throughput of the sequencing-based assays, barcoded DNA fragments have been used in several aspects of next-generation sequencing (NGS) approach. STUDY DESIGN, SIZE, DURATION: We developed an ETS that substantially alleviates the complexity of the current sequencing-based PGT. With (n = 693) and without (n = 192) ETS, the downstream PGT procedure was performed on both bulk DNA samples (n = 563) and whole-genome amplified (WGAed) few-cell DNA samples (n = 322). Subsequently, we compared full genome haplotype landscapes of both WGAed and bulk DNA samples containing ETS or no ETS. PARTICIPANTS/MATERIALS, SETTING, METHODS: We have devised an ETS to track embryos right after whole-genome amplification (WGA) to full genome haplotype profiles. In this study, we recruited 322 WGAed DNA samples derived from IVF embryos as well as 563 bulk DNA isolated from peripheral blood of prospective parents. To determine possible interference of the ETS in the NGS-based PGT workflow, barcoded DNA fragments were added to DNA samples prior to library preparation and compared to samples without ETS. Coverages and variants were determined. MAIN RESULTS AND THE ROLE OF CHANCE: Current PGT protocols are quality sensitive and prone to sample switching. To avoid sample switching and increase throughput of PGT by sequencing-based haplotyping, six control steps should be carried out manually and checked by a second person in a clinical setting. Here, we developed an ETS approach in which one step only in the entire PGT procedure needs the four-eyes principal. We demonstrate that ETS not only precludes error-prone manual checks but also has no effect on the genomic landscape of preimplantation embryos. Importantly, our approach increases efficacy and throughput of the state-of-the-art PGT methods. LIMITATIONS, REASONS FOR CAUTION: Even though the ETS simplified sequencing-based PGT by avoiding potential errors in six steps in the protocol, if the initial assignment is not performed correctly, it could lead to cross-contamination. However, this can be detected in silico following downstream ETS analysis. Although we demonstrated an approach to evaluate purity of the ETS fragment, it is recommended to perform a pre-PGT quality control assay of the ETS amplicons with non-human DNA, such that the purity of each ETS molecule can be determined prior to ETS-PGT. WIDER IMPLICATIONS OF THE FINDINGS: The ETS-PGT approach notably increases efficacy and scalability of PGT. ETS-PGT has broad applicative value, as it can be tailored to any single- and few-cell sequencing approach where the starting specimen is scarce, as opposed to other methods that require a large number of cells as the input. Moreover, ETS-PGT could easily be adapted to any sequencing-based diagnostic method, including PGT for structural rearrangements and aneuploidies by low-pass sequencing as well as non-invasive prenatal testing. STUDY FUNDING/COMPETING INTEREST(S): M.Z.E. is supported by the EVA (Erfelijkheid Voortplanting & Aanleg) specialty program (grant no. KP111513) of Maastricht University Medical Centre (MUMC+), and the Horizon 2020 innovation (ERIN) (grant no. EU952516) of the European Commission. TRIAL REGISTRATION NUMBER: N/A.
引用
- van Dijk W, Derks K, Drüsedau M, et al. Embryo tracking system for high-throughput sequencing-based preimplantation genetic testing. Hum Reprod. 2022. PMID: 36149256. doi:10.1093/humrep/deac208
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。